X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - FINANCIALPOST.COM - A La Une - 10/Jul 12:15

Enveric Biosciences Announces Patent Granted for Drug Candidate

US patent includes broad claims for treating brain neurological disorders CAMBRIDGE, Mass. — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, today announces the expansion of protection for potential clinical indications for its EB-002 drug candidate through the issuance […]

Articles similaires

Sorry! Image not available at this time

Unusual way to cleanse brain from toxic proteins found 21:23

socialbites.ca - 15/Aug 18:31

Scientists from the University of Rochester have found that the drug prostaglandin F2α, used to induce labor, helps clear toxic proteins from the...

Sorry! Image not available at this time

Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe

zacks.com - 21/Aug 14:46

Xenon's (XENE) clinical studies of azetukalner in epilepsy and other neurological disorders are progressing well. However, any setback is set to hurt...

Sorry! Image not available at this time

Understanding our brains during puberty: how sex differences in brain development affect mental health

themontrealeronline.com - 17/Aug 09:00

There are many neurological and neuropsychiatric diseases that affect men and women differently, but we don’t have a clear picture as to why. One...

Sorry! Image not available at this time

Prota Therapeutics Announces Publication in Allergy of Long-Term Peanut Allergy Study Confirming Clinical Remission as the Optimal Treatment Outcome

drugs.com - 15/Aug 00:08

MELBOURNE, Australia, Aug. 14, 2024. Prota Therapeutics Pty Ltd (Prota), an Australian clinical-stage biotechnology company focused on the development...

Sorry! Image not available at this time

Enrollment Completed for the SAD Part 1 of Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

drugs.com - 13/Aug 23:08

CAMBRIDGE, Mass., Aug. 13, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...

Sorry! Image not available at this time

MBX Biosciences’ $63.5 Million Series C Financing Round

globallegalchronicle.com - 14/Aug 00:00

Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on patent matters on the transaction. MBX Biosciences, Inc., a clinical-stage...

Sorry! Image not available at this time

Accutar Biotechnology Receives FDA Fast Track Designation for AC699 in ER+ / HER2- Breast Cancer

drugs.com - 14/Aug 01:08

CRANBURY, N.J.–(BUSINESS WIRE) Aug 14, 2024 –Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence...

Sorry! Image not available at this time

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

drugs.com - 15/Aug 20:08

CAMBRIDGE, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and...

Sorry! Image not available at this time

AlphaFold accelerates discovery of potential antipsychotic drugs by outperforming traditional methods

news.medical.net - 13/Aug 04:23

Researchers used AlphaFold and homology modeling to identify potent TAAR1 agonists, showing AlphaFold's superior performance in drug discovery for...

Sorry! Image not available at this time

Pacira (PCRX) Plummets as US Court Deems Exparel Patent Invalid

zacks.com - 12/Aug 13:37

Pacira (PCRX) falls 48% as the District Court of New Jersey rules that the company's '495 patent for its lead drug, Exparel, is not valid.

Les derniers communiqués